Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-14 Purchase |
2025-03-18 8:07 pm |
Lyell Immunopharma Inc. | LYEL | Klausner Richard Director |
158,000 | $0.6009 | $94,942 | 3,811,199 (Indirect Direct) |
View |
| 2023-08-15 Sale |
2023-08-17 4:23 pm |
Lyell Immunopharma Inc. | LYEL | Klausner Richard Director |
58,020 | $2.28 | $132,286 | 3,898,714 (Indirect Direct) |
View |
| 2022-09-23 Sale |
2022-09-27 6:14 pm |
Lyell Immunopharma Inc. | LYEL | Klausner Richard Director |
11,100 | $6.4001 | $71,041 | 3,956,734 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-14 Option Award |
2024-06-17 4:15 pm |
N/A 2034-06-13 |
Lyell Immunopharma Inc. | LYEL | Klausner Richard Director |
130,000 | $0 | 3,783,199 (Direct) |
View |
| 2023-09-08 Option Award |
2023-09-08 4:30 pm |
N/A 2033-09-07 |
Lyell Immunopharma Inc. | LYEL | Klausner Richard Director |
55,000 | $0 | 3,953,714 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-20 4:45 pm |
N/A 2033-06-15 |
Lyell Immunopharma Inc. | LYEL | Klausner Richard Director |
65,000 | $0 | 4,021,734 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:08 pm |
N/A 2032-06-07 |
Lyell Immunopharma Inc. | LYEL | Klausner Richard Director |
65,000 | $0 | 4,032,834 (Direct) |
View |
| 2021-06-21 Conversion |
2021-06-23 5:36 pm |
N/A N/A |
Lyell Immunopharma Inc. | LYEL | Klausner Richard Executive Chairman |
3,765,842 | $0 | 6,733,676 (Indirect) |
View |
Ownership |
2021-06-16 7:18 pm |
N/A N/A |
Lyell Immunopharma Inc. | LYEL | Klausner Richard Executive Chairman |
0 | $0 | 14,772,824 (Direct) |
View |